Dragon Pharma Cartalax 20 mg
Dragon Pharma's Cartalax 20 mg is a premium synthetic tripeptide bioregulator developed within the renowned Khavinson peptide research framework. With the precise amino acid sequence Alanine-Glutamic Acid-Aspartic Acid (Ala-Glu-Asp or AED), Cartalax is specifically designed to support cartilage health, joint function, and musculoskeletal tissue maintenance. This sophisticated peptide represents a targeted approach to addressing the joint-related concerns that are all too common among bodybuilders, athletes, and fitness enthusiasts.
The mechanism of action of Cartalax is centered on its ability to interact with chromatin—the complex of DNA and proteins within the cell nucleus—to modulate gene expression specifically in cartilage and connective tissue cells. This epigenetic regulatory mechanism allows Cartalax to influence the production of key structural proteins such as collagen, proteoglycans, and glycosaminoglycans, which are essential for maintaining the integrity and function of cartilage tissue. By promoting healthy gene expression patterns in chondrocytes (cartilage cells), Cartalax supports the body's natural cartilage maintenance and repair processes.
For bodybuilders and athletes, joint health is a critical concern that often goes unaddressed until problems arise. The repetitive heavy loading, high-impact movements, and intense training sessions that are hallmarks of bodybuilding can take a significant toll on joints, leading to cartilage degradation, inflammation, and chronic pain. The use of certain anabolic steroids can further compound these issues by affecting collagen synthesis and connective tissue health. Cartalax offers a research-based approach to supporting joint health at the cellular level, potentially helping to prevent and mitigate the joint damage associated with intense training.
Cartilage tissue is unique in that it has a limited capacity for self-repair. Unlike many other tissues, cartilage lacks a direct blood supply, meaning that nutrients and repair factors must diffuse through the tissue matrix. This avascular nature makes cartilage particularly vulnerable to degradation and slow to heal after injury. Cartalax's ability to influence gene expression in chondrocytes may help support the production of new matrix components, potentially aiding in the maintenance and repair of cartilage tissue. This is especially important for athletes who may be dealing with age-related cartilage changes or injury-related damage.
The Khavinson peptide bioregulators, including Cartalax, are distinguished by their ability to restore cellular function through gene-directed protein synthesis. This approach represents a paradigm shift in joint health optimization, moving beyond symptomatic treatment to genuine tissue-specific regulation and functional restoration. For athletes seeking comprehensive joint support, particularly those concerned about the long-term effects of training on their joints, Cartalax is an invaluable addition to their protocol.
Cartalax's effects extend beyond cartilage tissue to encompass the broader musculoskeletal system. The peptide may support the health of tendons, ligaments, and other connective tissues that are essential for joint stability and function. By promoting healthy cellular function in these tissues, Cartalax may help maintain joint integrity and reduce the risk of injuries that can sideline athletes from their training. This comprehensive approach to musculoskeletal health makes Cartalax a valuable tool for athletes of all levels.
The use of performance-enhancing compounds, particularly those with androgenic properties, can affect collagen synthesis and connective tissue health. While muscle tissue responds robustly to anabolic stimulation, tendons and ligaments may not experience the same strengthening effects, potentially leading to a muscle-tendon strength imbalance that increases injury risk. Cartalax's ability to support connective tissue health may help address this imbalance, promoting stronger, more resilient joints that can withstand the demands of heavy training.
Key Benefits:
- Cartilage Health Support: Promotes healthy gene expression in chondrocytes, supporting the production of collagen, proteoglycans, and other essential cartilage matrix components.
- Joint Function Maintenance: Supports the integrity and function of joints by promoting the health of cartilage, tendons, and ligaments.
- Cellular Regulation: Modulates gene expression in connective tissue cells through chromatin interaction, addressing joint health at the fundamental cellular level.
- Musculoskeletal Support: Supports the broader musculoskeletal system, promoting the health of all connective tissues essential for joint stability and function.
- Khavinson Bioregulation: Leverages the proven Khavinson peptide technology for targeted cellular restoration and gene expression optimization in cartilage tissue.
Each package contains one 2 mL glass vial with 20 mg of lyophilized Cartalax powder, manufactured under strict quality control standards in Dragon Pharma's certified European facilities. The product requires reconstitution with bacteriostatic water prior to use.
Product Specifications
| Product Name |
Cartalax 20 mg |
| Manufacturer |
Dragon Pharma |
| Substance |
Cartalax (Ala-Glu-Asp / AED) |
| Packaging |
2 mL Glass Vial (Lyophilized Powder) |
| Lab Test Result |
HPLC Verified (≥98% Purity) |
| Half-Life |
Approximately 2-3 hours |
| Recommended Cycle |
4-8 Weeks |
| Form |
Lyophilized Powder |
| Aromatization |
No |
| Dosage (Men) |
100-250 mcg per day |
Usage Guidelines
Cartalax is typically administered via subcutaneous or intramuscular injection after reconstitution with bacteriostatic water. Based on preclinical research and user experience, the following protocols have shown effectiveness for cartilage and joint health support.
- Beginner Protocol: 100 mcg administered once daily for 4 weeks. This dosage is recommended for first-time users to assess tolerance and initial joint support benefits.
- Intermediate Protocol: 150 mcg daily for 6 weeks. This is the most common protocol for general cartilage support and joint health maintenance.
- Advanced Protocol: 250 mcg daily, divided into two doses (morning and evening), for 8 weeks. This protocol is for those seeking maximum cartilage regeneration and joint support.
Recommended Stacking Strategies:
Cartalax can be effectively combined with other Dragon Pharma products for comprehensive joint and tissue support. For enhanced tissue regeneration and recovery, stacking with BPC-157 5 mg provides synergistic healing benefits for cartilage and connective tissue. For those seeking comprehensive inflammation reduction and joint support, TB-500 5 mg offers complementary regenerative effects. For enhanced overall recovery and musculoskeletal health, combining with GHRP-2 5 mg can support tissue repair and growth hormone release. For users focused on antioxidant and mitochondrial health, SS-31 50 mg pairs well with Cartalax's cartilage support properties.
Health & Ancillary Support:
While Cartalax does not affect hormonal pathways directly, maintaining overall joint and musculoskeletal health is essential for optimal results. For athletes using anabolic steroids, comprehensive health support is recommended—consider incorporating Atorvastatin 40 mg for lipid management. Additionally, proper nutrition with adequate collagen precursors, omega-3 fatty acids, and antioxidants is crucial to maximizing the benefits of this joint-supporting peptide.
Storage Instructions
Proper storage is essential to maintain the integrity and potency of Cartalax.
- Lyophilized Powder: Store in a cool, dry place away from direct light at room temperature (up to 25°C / 77°F).
- Post-Reconstitution: Once mixed with bacteriostatic water, the solution must be refrigerated at 2-8°C (36-46°F).
- Stability: Use the reconstituted solution within 28-30 days to ensure optimal peptide efficacy.
- Important: Do not freeze the reconstituted solution, as this can degrade the peptide structure.
Frequently Asked Questions
What is Cartalax and how does it work?
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson peptide bioregulator family. It works by interacting with chromatin in cartilage cells (chondrocytes) to modulate gene expression, promoting the production of collagen, proteoglycans, and other essential cartilage matrix components. This supports cartilage health, joint function, and musculoskeletal integrity.
How do I reconstitute Cartalax 20 mg?
To reconstitute Cartalax, add 2 mL of bacteriostatic water to the vial. Gently swirl until the powder is fully dissolved. Avoid shaking vigorously. This yields a concentration of 10 mg/mL for accurate dosing. Always use sterile techniques and equipment.
What are the recommended dosages for Cartalax?
Based on preclinical research and user experience, common dosages range from 100-250 mcg per day. Beginners should start at 100 mcg daily for 4 weeks, while more advanced users may work up to 250 mcg per day for 8 weeks. Always start with the lowest effective dose and monitor your joint response.
Can Cartalax be stacked with other peptides?
Yes, Cartalax stacks effectively with other peptides for enhanced joint and tissue support. Common combinations include BPC-157 for tissue healing, TB-500 for regeneration, GHRP-2 for growth hormone release, and SS-31 for mitochondrial health. Always research compatibility and use appropriate cycling protocols.
What are the benefits of Cartalax for bodybuilders and athletes?
Cartalax offers several benefits for athletes: supports cartilage health and joint function, promotes collagen production in connective tissues, addresses joint health at the cellular level, helps maintain musculoskeletal integrity under training stress, and may help prevent and mitigate joint damage associated with intense training. This makes it particularly valuable for athletes dealing with joint pain, age-related cartilage changes, or concerns about long-term joint health.
